Evidence map›Paper›PMID 38988165›Full record

ReviewCurrent drug discovery technologies2025

The Genus Paeonia: A Review of the Targeted Signaling Pathways and Underlying Mechanisms of Pharmacological and Clinical Properties.

Atefeh Jalali, Fereshteh Jafari, Shima Behnamrad, Mohammad M Zarshenas, Xiuxin Zhang, Ali Kashkooe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Atefeh JalaliMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Fereshteh JafariBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Shima BehnamradMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad M ZarshenasMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Xiuxin ZhangInstitute of Vegetables and Flowers, Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Chinese Academy of Agricultural Sciences, Ministry of Agriculture and Rural Affairs, Beijing, China.
Ali KashkooeMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Paeoniaceae family contains only the Paeonia genus and is considered a major group of flowering plants. Several traditional and pharmacological applications of Paeoniaceae herbs have been described. This paper aimes to determine the pharmacological activities of the most prevalent herbs from the genus Paeonia by focusing on their underlying mechanism of action and signaling pathways, providing insight for further in-depth research on the medicinal resources of Paeonia.

methodsThe "Paeoniaceae" keyword was searched from 1st January 1995 to 15th May 2024 through the PubMed and Scopus databases. Only papers related to pharmacology, pharmaceutics, and toxicology were extracted. The possible pharmacological activity of the Paeonia plants, including their underlying mechanisms of action and signaling pathways, was subsequently discussed.

resultsFollowing our venture, only 15 Paeonia herbs were adequately evaluated for their pharmacological applications.

conclusionAmong the applications of Paeonia herbs, anti-inflammatory and antioxidant activities are critical, as most other pharmacological effects are attributed to them. In other words, nuclear factor (NF)-κB and nuclear factor erythroid 2-related factor 2 (Nrf2) can be considered the most important signaling pathways involved in the pharmacological activity of Paeonia herbs.

Indexed as

PaeoniaPlant ExtractsSignal TransductionAnimalsHumansPhytotherapyPlant ExtractsAnti-inflammatoryantioxidantclinical propertiesNK-κBNrf2paeoniapharmacological properties.signaling pathway

Identifiers

PMID38988165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.